innate immune system
The evolutionarily older arm of immunity using cells like macrophages with built-in ('innate') signals that recognize broad classes of bacteria and viruses by their surface molecules.
As defined in 303 | James P. Allison on Fighting Cancer with the Immune System
Where it comes up · 3
- 303 | James P. Allison on Fighting Cancer with the Immune System2 claims
- 214 - A Conversation With Siddhartha Mukherjee1 claim
- Special Episode Engineering The Apocalypse1 claim
Most important claims · 4 of 4Search all claims for “innate immune system” →
- The adaptive immune system produces receptors by essentially random recombination of DNA sequences, theoretically capable of 10^15 to 10^17 different receptors, but since the body has only about 10^10 to 10^12 cells, each individual realizes only a tiny fraction of possible diversity—so the species is protected by the full repertoire but not necessarily any single individual.303 | James P. Allison on Fighting Cancer with the Immune System
- A T cell needs two simultaneous signals to activate: the antigen receptor acts as an ignition switch, but nothing happens unless a second signal—the CD28 'gas pedal'—is also pushed; solid tumors are invisible to the immune system precisely because they lack the structure that binds CD28, so the only way they get attacked is when tumor cell death triggers the innate immune system to come in and prime the T cells.303 | James P. Allison on Fighting Cancer with the Immune System
- The virus causes failure in two phases of the immune response: some people fail to produce a brisk type-1 interferon response (shown in a large Paris study and genetic studies) and never control their viremia, progressing to severe disease; a separate group controls the virus initially but then suffers 'immunological misfiring' where innate cells like macrophages and monocytes trigger uncontrolled inflammation—and whether these populations overlap or require distinct therapies is unknown.214 - A Conversation With Siddhartha Mukherjee
- The BCG tuberculosis vaccine appears to strengthen the innate immune system and provide broad-spectrum protection beyond TB—a 25-year study of 150,000 kids showed 40% fewer lower respiratory infections, a Greek study showed 80% fewer respiratory infections in older adults, and a PNAS study found COVID death rates dropped 10.4% per 10% increase in BCG coverage—yet definitive trials remain unfunded due to a market failure (it costs 7 cents a dose and is in the public domain).Special Episode Engineering The Apocalypse